To test this, we treated PGP knockout lines obtained from the HCT116 colorectal carcinoma and U2OS osteosarcoma cell line with Bleomycin, the chemotherapeutic agent that is best characterized to lead to the production of phosphoglycolate [42], and with ionizing radiation (Figure 5). This evidence concerns the gene PGP and colorectal carcinoma.